×

Browse

Oncology

articles
13
Dec

iBiopsy® for Precision Medicine
Oncology
A high-throughput artificial intelligence-powered image-based phenotyping platform, iBiopsy® (Median Technologies, Valbonne, France), which aims to…
06
Dec

The Right Therapy Starts with the Right Test: Novel Therapeutic Approaches in Oncology Foster the Need for an Appropriate Molecular Profiling Strategy
Oncology
Adding a molecular perspective to the traditional multidisciplinary management of cancer patients is substantially hampering the adoption of precision…
06
Dec

Prediction with Precision: Does TAILORx Make Chemotherapy a Personalised Treatment?
Oncology
Adjuvant chemotherapy (CT) is commonly recommended to breast cancer patients following surgery. However, not all patients benefit from it, and the…
06
Dec

Genomic Profiling Clinical Trials in Cancer of Unknown Primary
Oncology
Cancer of unknown primary (CUP) accounts for 3–5% of all cancers, and prognosis is poor for most patients, with a median survival of 6–9 months…
06
Dec

Editor's Pick: Novel Targets and Therapies in T Cell Lymphoma
Oncology
This review presents the recent advances in our understanding of the cellular pathogenesis of T cell non-Hodgkin lymphoma (NHL) and the potential of…
06
Dec

Recent Advances in the Treatment of Metastatic Soft Tissue Sarcoma
Oncology
Soft tissue sarcomas (STS) are a rare group of heterogeneous malignancies with >50 histologic subtypes that have varying biological behaviour and…
06
Dec

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
Oncology
Prostate cancer, with its remarkably high prevalence, frequently creates clinical problems in terms of screening and diagnosis, as well as identifying…
06
Dec

Mantle Cell Lymphoma: Are New Therapies Changing the Standard of Care?
Oncology
The prognosis of mantle cell lymphoma (MCL) has improved rapidly over recent years with the evolution of new management strategies. The disease, once…
www.biceps-ua.com

velotime.com.ua/category/velosipedy-bergamont/

также читайте